Efficacy Study of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive Coronary Artery Disease (CAD) Participants
Clinical trial NCT03010423 · TERMINATED
Trial details
- NCT number
- NCT03010423
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-30
- Primary completion
- 2019-07-09
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.